‘Can repeated intranasal oxytocin administration affect reduced neural sensitivity towards expressive faces in autism? A randomized controlled trial’
Paper from the JCPP
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by difficulties in social communication and interaction. Crucial for efficient social interaction is the ability to quickly and accurately extract information from a person’s face. Frequency-tagging electroencephalography (EEG) is a novel tool to quantify face-processing sensitivity in a robust and implicit manner. In terms of intervention approaches, intranasal administration of oxytocin (OT) is increasingly considered as a potential pharmacological approach for improving socio-communicative difficulties in ASD, through enhancing social salience and/or reducing (social) stress and anxiety.
Authors: Matthijs Moerkerke, Nicky Daniels, Stephanie Van der Donck, Laura Tibermont, Tiffany Tang, Edward Debbaut, Annelies Bamps, Jellina Prinsen, Jean Steyaert, Kaat Alaerts, Bart Boets
First published: 06 June 2023
ACAMH Members can read the full paper:
If you are not an ACAMH Member now is a great time to join from as just £5! Take a look at the different levels of membership on offer. Don’t forget as a charity any surplus made is reinvested back as we work to our vision of ‘Sharing best evidence, improving practice’, and our mission to ‘Improve the mental health and wellbeing of young people aged 0-25’.